Nautilus Biotechnology, Inc. (NAUT) — 分析师展望 / 分析师共识目标价为. 基于 5 位分析师评级, 共识为 看涨 — 3 买入, 1 持有, 1 卖出.
分析师共识目标价为 $2.50, 下跌空间为 23.1% 相对于当前价格 $3.25.
分析师预估 每股收益(EPS)为 $-0.45 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-0.56 vs 预期 $-0.45 (不及预期 -23.8%). 2025: 实际 $-0.47 vs 预期 $-0.53 (超预期 +10.5%). 分析师准确度: 85%.
NAUT 股票 — 12个月价格预测
$2.50
▼ -23.08% 下跌空间
平均目标价
Based on 5 Wall Street analysts offering 12-month price targets for Nautilus Biotechnology, Inc., the price target is $2.50.
平均目标价相对最新价格 $3.25 变动 -23.08%。
NAUT 分析师评级
Buy
基于过去3个月内 5 位分析师对 Nautilus Biotechnology, Inc. 的评级
EPS 预测 — NAUT
85%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.56
vs Est –$0.45
▼ 19.2% off
2025
Actual –$0.47
vs Est –$0.53
▲ 11.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — NAUT
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
